Equillium Enterprise Value Over E B I T D A from 2010 to 2024

EQ Stock  USD 0.71  0.01  1.39%   
Equillium Enterprise Value Over EBITDA yearly trend continues to be relatively stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -0.23. During the period from 2010 to 2024, Equillium Enterprise Value Over EBITDA destribution of quarterly values had range of 131 from its regression line and mean deviation of  63.87. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(0.22)
Current Value
(0.23)
Quarterly Volatility
66.27413147
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Equillium financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Equillium's main balance sheet or income statement drivers, such as Interest Income of 2.1 M, Interest Expense of 748.9 K or Selling General Administrative of 10.3 M, as well as many indicators such as Price To Sales Ratio of 0.66, Dividend Yield of 0.0 or PTB Ratio of 1.17. Equillium financial statements analysis is a perfect complement when working with Equillium Valuation or Volatility modules.
  
Check out the analysis of Equillium Correlation against competitors.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

Latest Equillium's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Equillium over the last few years. It is Equillium's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Equillium's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Equillium Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(70.45)
Geometric Mean13.37
Coefficient Of Variation(94.08)
Mean Deviation63.87
Median(130.32)
Standard Deviation66.27
Sample Variance4,392
Range131
R-Value0.87
Mean Square Error1,132
R-Squared0.76
Significance0.000022
Slope12.93
Total Sum of Squares61,492

Equillium Enterprise Value Over E B I T D A History

2024 -0.23
2023 -0.22
2022 0.22
2021 -1.8
2020 -3.25
2019 -2.18
2018 -6.66

About Equillium Financial Statements

Equillium shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Equillium investors may analyze each financial statement separately, they are all interrelated. The changes in Equillium's assets and liabilities, for example, are also reflected in the revenues and expenses on on Equillium's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(0.22)(0.23)

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

  0.57RNXT RenovoRxPairCorr
  0.55MDGL Madrigal PharmaceuticalsPairCorr
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Equillium Stock Analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.